FNAC Procedure & Reporting (Thyroid) at Test Zone Diagnostic Center

FNAC Procedure & Reporting (Thyroid) at Test Zone Diagnostic Center

A thyroid nodule is a highly common clinical finding that requires precise diagnostic evaluation to rule out malignancy and guide clinical management. Fine Needle Aspiration Cytology (FNAC) is the gold standard, minimally invasive procedure used to evaluate thyroid nodules and determine whether they are benign, suspicious, or malignant. At Test Zone Diagnostic Center, we provide comprehensive FNAC Procedure & Reporting (Thyroid) services, combining advanced ultrasound-guided localization with expert cytopathological analysis to deliver highly accurate results. This diagnostic investigation allows clinicians to make informed decisions regarding patient care, avoiding unnecessary surgical interventions for benign conditions while ensuring timely treatment for malignant diseases.

The thyroid gland, located at the base of the neck, plays a vital role in regulating metabolism, growth, and development through the secretion of thyroid hormones. When nodules or masses develop within the thyroid parenchyma, they can be detected through physical examination or routine neck imaging. While the majority of thyroid nodules are benign, a small percentage represent thyroid carcinoma. FNAC serves as a crucial bridge between clinical imaging and definitive diagnosis. By extracting cellular samples directly from the nodule using a very thin needle, cytopathologists can examine the cellular morphology and architecture, providing a highly specific diagnosis without the need for a surgical biopsy.

At Test Zone Diagnostic Center, we utilize high-resolution ultrasound guidance to perform thyroid FNAC. Ultrasound-guided FNAC significantly increases the diagnostic yield and accuracy of the procedure compared to palpation-guided biopsies, especially for small, non-palpable, or deeply situated nodules. The real-time imaging allows our specialists to precisely target the solid or suspicious components of a nodule, avoiding cystic fluid or necrotic areas that could lead to non-diagnostic or unsatisfactory samples. This advanced approach ensures that the collected specimen contains high-quality cellular material, minimizing the need for repeat procedures and providing patients with peace of mind.

Clinical Procedure: What to Expect

Patient Preparation

Proper preparation is essential to ensure a safe, smooth, and successful thyroid FNAC procedure. Patients are advised to follow these guidelines prior to their appointment at Test Zone Diagnostic Center:

• Medication Review: Inform the clinical team about all medications you are currently taking. Blood thinners, anticoagulants, or antiplatelet medications (such as aspirin, warfarin, clopidogrel, or heparin) may need to be temporarily discontinued 3 to 5 days before the procedure, under the guidance of your prescribing physician, to minimize the risk of bleeding or hematoma formation.
• No Fasting Required: Unlike surgical biopsies, fasting is not required for a thyroid FNAC. You may eat a light meal and drink fluids normally before the procedure.
• Clothing: Wear comfortable, loose-fitting clothing. A button-down shirt or a top with a wide neck is highly recommended to allow easy access to the neck area. Please avoid wearing necklaces or other jewelry around the neck.
• Medical Records: Bring all previous diagnostic reports, including thyroid ultrasound scans, thyroid function test (TFT) results, and relevant clinical notes, to assist the performing specialist.
• Anxiety Management: The procedure is minimally invasive and generally well-tolerated. Local anesthesia is typically not required as the needle used is thinner than a standard blood-drawing needle, but a topical numbing cream can be applied if a patient is highly anxious.

During the Procedure

The thyroid FNAC procedure at Test Zone Diagnostic Center is performed in a controlled, sterile environment by an experienced clinical team. Here is what you can expect during the session:

• Patient Positioning: You will be asked to lie flat on your back on an examination table with a pillow placed under your shoulders. This position helps to extend your neck, making the thyroid gland more accessible.
• Skin Sterilization: The skin over your neck will be thoroughly cleaned with an antiseptic solution (such as chlorhexidine or alcohol) to maintain a sterile field and prevent infection.
• Ultrasound Localization: The radiologist or specialist will apply a sterile gel to your neck and use an ultrasound probe to identify the target thyroid nodule. The nodule’s size, depth, and characteristics are assessed in real-time.
• Needle Insertion: Under direct ultrasound visualization, a very fine, sterile needle (typically 23 to 27 gauge) attached to a syringe is gently inserted through the skin into the thyroid nodule. The ultrasound guidance ensures the needle tip is positioned precisely within the target area.
• Sample Aspiration: The specialist will perform gentle suction or capillary action while moving the needle slightly within the nodule to collect cellular material. This process takes only 10 to 15 seconds per pass. Usually, 2 to 4 passes are made in different areas of the nodule to ensure an adequate and representative sample.
• Sensation and Comfort: You may feel a mild pressure or pinching sensation in your neck during the needle insertion. You will be instructed to remain still, avoid swallowing, and refrain from speaking or coughing during the brief seconds the needle is inside the nodule.
• Post-Procedure Care: Once the sample is collected, the needle is withdrawn, and firm pressure is applied to the puncture site with sterile gauze for several minutes to prevent bleeding. A small adhesive bandage is then applied. The entire procedure takes approximately 15 to 30 minutes.

When is a FNAC Procedure & Reporting (Thyroid) Performed?

Evaluation of Palpable Thyroid Nodules

Physicians request a thyroid FNAC when a patient presents with a palpable lump or mass in the anterior neck. During physical examinations, clinicians may detect an enlargement of the thyroid gland or a distinct nodule. FNAC is performed to evaluate the nature of these palpable masses, helping to distinguish between benign conditions, such as colloid nodules or thyroid cysts, and malignant neoplasms. This initial triage is vital for determining whether the patient requires surgical resection or conservative monitoring.

Investigation of Suspicious Ultrasound Findings

With the widespread use of high-resolution neck imaging, many thyroid nodules are discovered incidentally. Radiologists classify these nodules using the Thyroid Imaging Reporting and Data System (TI-RADS). If an ultrasound scan reveals suspicious features—such as microcalcifications, marked hypoechogenicity, irregular or lobulated margins, a taller-than-wide shape, or extrathyroidal extension—an FNAC is indicated. The procedure helps confirm whether these imaging characteristics correlate with cellular malignancy.

Assessment of Rapidly Enlarging Neck Masses

A rapidly growing thyroid mass is a clinical red flag that warrants immediate diagnostic investigation. Rapid enlargement can be a symptom of aggressive thyroid malignancies, such as anaplastic thyroid carcinoma or primary thyroid lymphoma, or it may represent an acute hemorrhage into a pre-existing benign cyst. Performing an urgent FNAC allows pathologists to rapidly analyze the cellular composition of the mass, enabling swift clinical intervention and treatment planning.

Monitoring of Known Multinodular Goiter

Patients with long-standing multinodular goiter require periodic clinical and ultrasound surveillance. If a previously stable nodule exhibits significant interval growth, or if a new dominant, suspicious nodule develops within the goiter, an FNAC is performed. This targeted investigation ensures that any localized malignant transformation within a background of benign multinodular disease is detected early, allowing for localized surgical management rather than total thyroidectomy when appropriate.

Diagnosis of Unexplained Cervical Lymphadenopathy

In some cases, thyroid cancer first presents as enlarged, painless lymph nodes in the lateral neck (cervical lymphadenopathy). If an ultrasound of the neck reveals suspicious lymph nodes alongside a thyroid nodule, an FNAC of both the thyroid nodule and the suspicious lymph node is performed. Detecting thyroid follicular or papillary cells within a cervical lymph node confirms metastatic thyroid disease, which is critical for staging and planning extensive surgical neck dissection.

What Does a FNAC Procedure & Reporting (Thyroid) Detect?

Thyroid FNAC is highly effective at detecting a wide range of benign, inflammatory, suspicious, and malignant thyroid conditions. The cytopathological report at Test Zone Diagnostic Center is structured according to the standardized Bethesda System for Reporting Thyroid Cytopathology. The procedure can detect and identify:

• Colloid Nodules: Benign accumulations of colloid fluid and follicular cells, which are the most common non-neoplastic thyroid lesions.
• Adenomatoid Hyperplasia: Benign proliferation of thyroid follicular cells commonly seen in multinodular goiters.
• Thyroid Cysts: Fluid-filled lesions that often contain macrophages, degenerated cellular debris, and minimal follicular epithelium.
• Hashimoto’s Thyroiditis: An autoimmune inflammatory condition characterized by an abundance of lymphocytes, plasma cells, and Hurthle (oncocytic) cells.
• De Quervain’s (Subacute) Thyroiditis: Granulomatous inflammation featuring multinucleated giant cells, histiocytes, and degenerated follicular cells.
• Acute Suppurative Thyroiditis: A rare bacterial infection of the thyroid gland showing dense neutrophilic infiltrates and necrotic debris.
• Atypia of Undetermined Significance (AUS): Cellular features that are mildly abnormal but not sufficient to be classified as neoplastic or suspicious (Bethesda Category III).
• Follicular Lesion of Undetermined Significance (FLUS): A borderline category indicating the presence of follicular cells with minor structural or nuclear atypia.
• Follicular Neoplasm: A cellular specimen showing a highly crowded, microfollicular pattern with minimal colloid, suggestive of a follicular adenoma or carcinoma (Bethesda Category IV).
• Hurthle Cell Neoplasm: A specific subtype of follicular neoplasm dominated by a monomorphic population of oncocytes (Hurthle cells).
• Papillary Thyroid Carcinoma (PTC): The most common form of thyroid cancer, characterized by classic nuclear features such as intranuclear pseudoinclusions, nuclear grooves, and psammoma bodies.
• Follicular Variant of Papillary Thyroid Carcinoma: A subtype of PTC showing a follicular growth pattern but retaining the diagnostic nuclear features of papillary carcinoma.
• Medullary Thyroid Carcinoma (MTC): A neuroendocrine tumor arising from the parafollicular C-cells, cytologically presenting with plasmacytoid or spindle-shaped cells and amyloid deposits.
• Anaplastic Thyroid Carcinoma: A highly aggressive, undifferentiated malignancy characterized by marked cellular pleomorphism, giant cells, spindle cells, and atypical mitotic figures.
• Primary Thyroid Lymphoma: A rare malignant lymphoproliferative disorder, often arising in a background of Hashimoto’s thyroiditis, showing a monomorphic population of atypical lymphocytes.
• Metastatic Malignancy to the Thyroid: Secondary tumors originating from distant organs, most commonly the kidneys, lungs, breast, or skin (melanoma).
• Nondiagnostic/Unsatisfactory Specimens: Samples that lack sufficient follicular epithelial cells (fewer than 6 groups of 10 cells) or are obscured by blood, requiring a repeat FNAC.
• Cystic Degeneration: Evidence of chronic bleeding, hemosiderin-laden macrophages, and tissue repair within a nodule.
• Amyloid Deposits: Extracellular proteinaceous material characteristic of medullary thyroid carcinoma, which can be confirmed with special stains like Congo Red.
• Psammoma Bodies: Microscopic, laminated calcifications highly associated with papillary thyroid cancer.
• Intranuclear Pseudoinclusions: Invaginations of the cytoplasm into the nucleus, a key diagnostic cytological feature of papillary thyroid carcinoma.
• Nuclear Grooves: Longitudinal folds in the nuclear membrane of follicular cells, commonly observed in papillary thyroid carcinoma.
• Oncocytic Metaplasia: Benign cellular changes where follicular cells become large and eosinophilic, often in response to chronic inflammation.
• Granulomatous Inflammation: Clusters of epithelioid histiocytes indicating a granulomatous response, seen in subacute or tuberculous thyroiditis.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand that waiting for biopsy results can be an anxious time for patients and their families. Our laboratory and pathology departments are optimized to process, stain, and interpret thyroid cytopathology slides with both speed and clinical precision. Once the FNAC sample is collected, the slides are prepared immediately in the procedure room to preserve cellular morphology. They are then transferred to our specialized histopathology laboratory, where they undergo Papanicolaou, Giemsa, or Hematoxylin and Eosin (H&E) staining.

The stained slides are meticulously reviewed by our consultant cytopathologists. To ensure the highest level of diagnostic accuracy, complex or borderline cases (such as Bethesda Category III or IV) undergo a secondary review process by a senior pathologist. The final report is typically completed and verified within 3 to 5 working days. Patients can access their reports online through the Test Zone Diagnostic Center web portal or mobile application, or they can collect a printed copy directly from our main reception desk. An SMS notification is sent to the patient’s registered mobile number as soon as the report is ready.

FNAC Procedure & Reporting (Thyroid) Findings Overview

The following table provides an overview of the structural and cellular parameters evaluated during a thyroid FNAC, comparing normal or benign findings with potential abnormal or malignant findings:

Structure / Parameter Evaluated	Normal / Benign Findings	Possible Abnormal / Malignant Findings
Cellularity	Adequate follicular cells arranged in flat, cohesive, monolayered sheets.	Hypercellularity with crowded, overlapping clusters, microfollicles, or single atypical cells.
Colloid Content	Abundant, thin, watery colloid evenly distributed across the slide.	Scant, thick,